A Pilot Study of Changing Medication Adherence In Hypertensive African-American Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00248937|
Recruitment Status : Completed
First Posted : November 4, 2005
Last Update Posted : April 3, 2008
|Condition or disease||Intervention/treatment||Phase|
|Hypertension||Behavioral: Positive affect and self-affect induction||Not Applicable|
We are interested in achieving an empirical test of the two intervention approaches under study. Specifically, we seek to determine the potential differential impact of positive affect induction and self affirmation following the qualitative phase.
Positive affect induction: We will tests two types of positive affect induction. 1) sending patients a small gift, and 2) reminding patients of positive thoughts about themselves.
Gift: Prior to a telephone call, patients in the positive affect condition will receive a small gift.
Positive thoughts about themselves: Patients will be asked to describe a time when someone was helpful to them, and they felt good about it , and were nice to them in return.
- Self affirmation: consists of a series of items reminding people of their core values.
- Control: Control patients will have neither self affirmation nor gifts.
Follow-up: At two weeks after enrollment all patients will be called to ascertain impact of the pilot intervention.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Pilot Study of Changing Medication Adherence In Hypertensive African-American Patients|
|Study Start Date :||February 2004|
|Study Completion Date :||June 2004|
- Within patient change on the Positive and Negative Affect Scale
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00248937
|United States, New York|
|The New York Presbyterian Hospital-Weill Medical Center|
|New York, New York, United States, 10021|
|Principal Investigator:||Carla Boutin-Foster, MD, MS||Weill Medical College of Cornell University|
|Principal Investigator:||Gbenga Ogedegbe, MD, MS||Columbia University|
|Study Director:||Mary E Charlson, MD||Weill Medical College of Cornell University|